1H-Azepine-3,4,5,6-tetrol,hexahydro-, (3S,4S,5S,6S)- (280745-41-7)

Identification
Name:	1H-Azepine-3,4,5,6-tetrol,hexahydro-, (3S,4S,5S,6S)-
Synonyms:	(3S,4S,5S,6S)-3,4,5,6-TETRAHYDROXYAZEPANE HCL;(3S,4S,5S,6S)-3,4,5,6-TETRAHYDROXYAZEPANE HCL SALT;(3S,4S,5S,6S)-3,4,5,6-TETRAHYDROXYAZEPANE HYDROCHLORIDE;1H-Azepine-3,4,5,6-tetrol, hexahydro-, (3S,4S,5S,6S)-
CAS:	280745-41-7
Molecular Formula:	C6H13 N O4
Molecular Weight:	199.63
Molecular Structure:
Properties
Safety Data

Other Product

1H-Azepine-3,4,5,6-tetrol,1-(diphenylmethyl)hexahydro-, (3S,4S,5S,6S)-
1H-Azepine-3,4,5,6-tetrol, hexahydro-, (3R,4S,5R,6S)-rel-
1H-Azepine-3,4,5,6-tetrol,hexahydro-, (3S,4R,5R,6S)-
1H-Azepine-3,4,6-triol,hexahydro-, (3S,4S,6S)-
1H-Azepine-3,4,5,6-tetrol, hexahydro-, (3R,4R,5R,6S)-
Naphthalene,decahydro-1,1,4a,6-tetramethyl- 5-[2-[(3S,3aR,4S,5S,7aS)-octahydro-5,7adimethyl- 3-(1-methylethyl)-1H-inden-4-yl]- ethyl]-,(4aR,5S,6S,8aS)-
(5S)-5-amino-N~2~-[(3S,4S,5S,6S)-3-(dichloromethyl)-1,5,6-trihydroxy-3-methyl-8-oxo-4,4a,5,6,7,8-hexahydro-3H-isochromen-4-yl]-4-oxo-L-norleucinamide
1H-Cyclopentcisoxazole-3,4,5,6-tetrol, hexahydro-1-methyl-, 3S-(3.alpha.,3a.beta.,4.beta.,5.alpha.,6.beta.,6a.beta.)-
N-[(2S,3S,4R,5S,6S)-2-[(2S,3S,4S,5S,6S)-2-[(2S,3S,4R,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)tetrahydropyran-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-4-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy
N-[(2S,3S,4R,5S,6S)-2-[(2S,3S,4S,5S,6S)-2-[(2S,3S,4R,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)tetrahydropyran-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3S,4S,5R,6S)-3,4,5-trihydroxy
(2R,3S,4R,5R,6S)-5-acetamido-3-[(2S,3R,4S,5S,6R)-4-[(2S,3R,4S,6S)-3-acetami]
2-[(2S,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[[(2R,3S,4R,5R,6S)-3-[3-[(2R,3S,4S,5R,6S)-2-[[(2S,3R,4S,5S,6R)-3,5-bis(2-diethylaminoethoxy)-6-[[(2S,3R,4R,5S,6R)-5-(2-diethylaminoethoxy)-3,4-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]-4-hydroxy-
(2S,3S,4S,5S,6S)-4,5-dibenzyloxy-2-(benzyloxymethyl)-6-(4-methoxyphenoxy)tetrahydropyran-3-ol
4a,9a-Epoxyanthracene-1,9,10(2H)-trione,4-[(1R)-1-(acetyloxy)ethyl]-7-[(5S,6S)-5-[(1R)-1-(acetyloxy)ethyl]-5,6,7,8,9,10-hexahydro-1,6-dihydroxy-6-methyl-8,9,10-trioxo-2-anthracenyl]-3,4-dihydro-3,8-dihydroxy-3-methyl-,(3S,4S,4aR,9aR)- (9CI)
1H-Azepine-3,4,6-triol,hexahydro-, (3R,4S,6S)-
(2R,3S,4S,5S,6R)-6-[(2S,3S,4R,5S,6S)-3-acetamido-2-[(2R,3S,4R,5S,6R)-6-[(3S,4R,5S,6S)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-4-yl]oxy-2-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)tetrahydropyran-4-yl]oxy-
(2R,3S,4S,5S,6R)-6-[(2S,3S,4R,5S,6S)-3-acetamido-2-[(2R,3S,4R,5S,6R)-6-[(2S,3S,4R,5S,6S)-3-acetamido-2-[(2R,3S,4R,5S,6R)-6-[(3S,4R,5S,6S)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-4-yl]oxy-2-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-
1H-Azepine-1-carboxylic acid,hexahydro-4-hydroxy-3-[[4-(phenylmethoxy)benzoyl]amino]-,1,1-dimethylethyl ester, (3S,4S)-
(E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; (2R,3R,4S,5S,6R)-6-(hydroxymethyl)tetrahydropyran-2,3,4,5-tetrol; (2R,3R,4R,5R,6S)-6-methyltetrahydropyran-2,3,4,5-tetrol
(2S)-4-{[(2R,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3R,4R,5S,6R)-3-(acetylamino)-5-{[(2S,3S,4S,5R,6S)-4-{[(2S,3S,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyra